Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Sarepta Plunges As FDA Takes Surprise Turn; AdComm Meeting Set For Duchenne Gene Therapy
March 17, 2023
Tickers
RHHBY
SRPT
Tags
Market News
FDA
Benzinga
From
Benzinga
FDA Casts Doubts Over Roche's Polivy Label Expansion For Untreated Lymphoma Setting
March 09, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
Large Cap
Biotech
Health Care
From
Benzinga
The Top 7 Growth Stocks in Biotech
March 03, 2023
Tickers
APVO
BEAM
CMRX
DVAX
Tags
CMRX
BEAM
RHHBY
From
InvestorPlace
Roche, Exelixis Report Second Flop Out Of Three Trials Evaluating Cabozantinib/Atezolizumab Combo
March 03, 2023
Tickers
EXEL
RHHBF
RHHBY
RHHVF
Tags
Briefs
News
RHHBY
From
Benzinga
Why Sarepta Therapeutics' Shares Rose 23.4% This Week
March 02, 2023
Tickers
RHHBY
SRPT
Tags
Recent Press Releases
RHHBY
Market News
From
Motley Fool
3 Best Growth Stocks to Buy In March
March 02, 2023
Tickers
HIMS
IWF
MELI
RHHBY
Tags
SRPT
MELI
RHHBY
From
Motley Fool
Blueprint Medicines Highlights Detailed Data From Lead Product In Blood Cancer Patients
February 27, 2023
Tickers
BPMC
RHHBY
Tags
BPMC
Market News
Benzinga
From
Benzinga
Roche Decides To Terminate Cancer Treatment Pact With Blueprint Medicines
February 23, 2023
Tickers
BPMC
RHHBF
RHHBY
RHHVF
Tags
Contracts
Biotech
Health Care
From
Benzinga
Infinity Pharmaceuticals Announce Merger Agreement With MEI Pharma, Share Plunge
February 23, 2023
Tickers
ABBV
INFI
MEIP
MRK
Tags
Briefs
News
Movers
From
Benzinga
New Data Shows Roche's Vabysmo Improves Vision, Retinal Fluid In Retinal Disorder
February 10, 2023
Tickers
REGN
RHHBF
RHHBY
RHHVF
Tags
Market News
Benzinga
Eurasia
From
Benzinga
Roche Touts Positive Crovalimab Data From Late-Stage Study In Rare Blood Condition
February 07, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
General
RHHBY
Health Care
From
Benzinga
Roche Flags Lower 2023 Sales On Declining Demand For COVID-19 Treatment, Diagnostics
February 02, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
Guidance
RHHVF
RHHBF
From
Benzinga
Roche Introduces Test To Detect Contagious XBB.1.5 Omicron Sub-Variant
January 26, 2023
Tickers
RHHBF
RHHBY
Tags
RHHBY
Briefs
News
From
Benzinga
Genentech's Tecentriq Plus Avastin Combo Cuts Risk of Cancer Returning In Early-Stage Liver Cancer
January 19, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
Health Care
Large Cap
Biotech
From
Benzinga
Trading Volume In The OTCQB Venture Market Picks Up in December – A Summary Of OTC Market Group's Most Active List In December
January 17, 2023
Tickers
AERG
ATLX
CLNV
CYDY
Tags
CYDY
NBLD
REII
From
Benzinga
Europe Approves Xofluza, Roche's Revolutionary Influenza Antiviral with New Mechanism
January 12, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
Biotech
Large Cap
European Medicines Agency
From
Benzinga
Twitter Hackers Stole More Than 200M Emails, Delta Air Lines To Offer Free Wi-Fi, Bed Bath & Beyond's Bankruptcy Coming Sooner Than Expected: Top Stories Today
January 06, 2023
Tickers
BBBY
CRM
DAL
PFE
Tags
Guidance
DAL
STLA
From
Benzinga
Roche's Investigational Lymphoma Candidate Goes Under FDA Priority Review
January 06, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHBF
RHHVF
News
From
Benzinga
Better Large-Cap Buy: Roche Holding or Gilead Sciences Stock?
January 02, 2023
Tickers
GILD
RHHBY
Tags
RHHBY
Recent Press Releases
Market News
From
Motley Fool
Roche's Follicular Lymphoma Therapy Scores FDA Approval
December 23, 2022
Tickers
BIIB
RHHBF
RHHBY
RHHVF
Tags
RHHVF
RHHBF
Briefs
From
Benzinga
FDA Approves Roche's Tocilizumab As First Monoclonal Antibody For COVID-19 Treatment
December 22, 2022
Tickers
LLY
RHHBF
RHHBY
RHHVF
Tags
RHHVF
RHHBF
RHHBY
From
Benzinga
Gilead Sciences (GILD) Stock Falls on Lung Cancer Drug Data
December 20, 2022
Tickers
GILD
MRK
RCUS
RHHBY
Tags
RHHBY
NASDAQ:GILD,NYSE:RCUS,OTCMKTS:RHHBY,NYSE:MRK
RCUS
From
InvestorPlace
OTC Market Group's Most Active List In November: A Dive Into The Names Experiencing Volume Changes
December 13, 2022
Tickers
AAUKF
ASMIY
ATLX
BDRBF
Tags
CWGL
CYDY
FISOF
From
Benzinga
Roche Presents New Data Demonstrating Potential Benefit Of Two Lymphoma Candidates
December 12, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
Market News
RHHVF
Benzinga
From
Benzinga
Broadcom-Vmware Deal Draws European Regulatory Attention, Rivian Pauses Mercedes-Partnered EV Van Plans For Europe, Credit Suisse Issued Loan On Suspicious Bills: Top Stories Monday, Dec. 12
December 12, 2022
Tickers
AAL
AMGN
AMKBY
AMZN
Tags
M&A
AMZN
RIVN
From
Benzinga
After 16 Years, Roche's Pharma Division Head Decides To Step Down
December 12, 2022
Tickers
NSRGY
RHHBF
RHHBY
RHHVF
Tags
News
Briefs
Management
From
Benzinga
Exelixis' Cabometyx/Tecentriq Combo Misses Overall Survival Goal In Lung Cancer Setting
December 09, 2022
Tickers
EXEL
IPSEY
RHHBY
TAK
Tags
General
RHHBY
Health Care
From
Benzinga
3 Hot Stocks That Could Live Up to Their Lofty Valuations
December 08, 2022
Tickers
ABBV
GMAB
GTBIF
JNJ
Tags
GMAB
NVS
ABBV
From
Motley Fool
Replimune Shares Surge After Early Data From Pretreated Melanoma Patients
December 07, 2022
Tickers
BMY
REPL
RHHBF
RHHBY
Tags
REPL
Market News
Benzinga
From
Benzinga
Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors
December 02, 2022
Tickers
AMGN
CHRS
CYTK
IBB
Tags
AIDS
IMGN
Top Stories
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.